Oxidative stress, ionizing radiation and chemotherapy agents including topoisomerase II (Top2) poisons such as etoposide can all promote therapy-induced senescence. The current paradigm is that DNA damage signaling is the common determinant of cellular senescence, whether induced by telomere erosion or chromosomal double strand breaks. However, our recent studies have implicated lipid peroxidation and resulting production of reactive lipid species (RLS) as key mediators of this pathway. This proposed work will examine Top2 as the critical target of RLS that promotes accelerated senescence. Here, we will apply biochemical and molecular tools to examine Top2 cysteine thiols as potential sites for modification by RLS such as 4-hydroxynonenal (4-HNE). We will determine if RLS modifications induce formation of the stable Top2-DNA cleaved complex (Top2cc), resulting in DNA double strand breaks and cellular senescence. To directly test whether DNA damage is indeed sufficient for senescence, we will apply Cas9 and promiscuous gRNAs as a source of pure double strand breaks. Further, combining Cas9-directed damage with RLS will provide a test of whether the two signals act in the same or distinct pathways. We will also pursue proteome- wide analysis of potential targets of RLS beyond Top2 that may regulate senescence. We will extend the work to evaluate the role of RLS in Top2 poisoning in vivo, using syngeneic tumors in mice. We will also use genetic depletion of senescent tumor cells formed after etoposide or radiation as a means to evaluate the relevance of therapy-induced senescence to tumor response to genotoxic therapy. This work may establish a new mechanism of action for etoposide and related chemotherapy agents as indirect topoisomerase poisons and pro-senescent drugs, with potential for impacts on their clinical use, both alone and in combination with other agents.

Public Health Relevance

Chemotherapy and radiation target cancer cells via multiple effects. Most studies have focused on how treatment damages cancer cell DNA while ignoring chemical changes in the lipid molecules in cell membranes. The highly reactive intermediates that result from this lipid damage are the focus of this project. We hope to elucidate a new mechanism of action for cancer therapy, where lipid and DNA damage combine to stop cancer cell proliferation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA217182-03
Application #
9710610
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Okano, Paul
Project Start
2017-07-01
Project End
2022-06-30
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
3
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Chicago
Department
Genetics
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Flor, Amy C; Wolfgeher, Don; Wu, Ding et al. (2017) A signature of enhanced lipid metabolism, lipid peroxidation and aldehyde stress in therapy-induced senescence. Cell Death Discov 3:17075